Seizures and Epilepsy Overview

Definitions

Epidemiology

Seizure types and Classification

Clinical features (semiology)

Aetiology

Specific Epilepsy Syndromes

Patient Evaluation

Differential diagnoses

Treatment:

Specific Issues

Driving (See Driving and Neurological Disease)

Epilepsy and Suicide

SUDEP (Sudden unexpected death in epilepsy)

Epilepsy and Pregnancy

Epilepsy and female hormones – menstruation and menopause

References

 

Definitions

Seizure

•   The clinical manifestations of an abnormal and excessive excitation of a population of neurons

Epilepsy

•   Recurrent seizures which are unprovoked by systemic or neurologic insults

•   ILAE – “a disorder of the brain characterized by an enduring predisposition to generate epileptic seizures”

•   Requires the “occurrence of at least one unprovoked seizure”

Acute symptomatic seizures (ILAE 2009) - Acute symptomatic seizures

•   Seizures occurring in close temporal relationship with an acute CNS insult

•   Acute symptomatic seizures differ from unprovoked seizures in risk of seizure recurrence and mortality.

•   Seizures are considered acute symptomatic if they occur within the first 7 days of cerebrovascular disease; TBI, including intracranial surgery; CNS infections, multiple sclerosis relapse. Longer timeframes may be appropriate depending on the ‘activity’ of the underlying condition (e.g. a flare of an infectious lesion or a further bleed from an AVM).

•   For alcohol withdrawal the seizure must occur within 7–48 h of the last drink.

•   Seizures in the setting of a brain tumour may more appropriately classified as epilepsy

Drug resistant epilepsy (ILAE 2009) – replaces term refractory epilepsy

•   Failure of adequate trials of two tolerated and appropriately chosen and used AED schedules (whether as monotherapies or in combination) to achieve sustained seizure freedom

Epidemiology

•   5-10% of the population will have a seizure in their lifetime

•   25-30% due to acute brain disturbance

•   30% of people who ever have a seizure will eventually be diagnosed with epilepsy

Recurrence rate in acute brain disturbance (see below for more details)

•   If no structural damage – less than 3%

•   If structural damage 12.5% (1/8)

Recurrence rate if unprovoked:

•   After one seizure 30-50%

•   After 2 unprovoked seizures 70-80% -diagnosis of epilepsy

 

If a second seizure is to occur 60-70% occur within 6 months

Epilepsy

•        Incidence 0.3-0.5%

•        Prevalence 0.5-1%

•        Lifetime risk 1.4%-3.3%

Seizure types and Classification

Seizure Classification

 

 

Focal

•   Predominant symptoms at onset

o   Use the earliest prominent symptom

o   Brief behavioural arrest is common but not used as a descriptor unless it remains the prominent symptom

o   The descriptor may not be the most prominent feature of the entire seizure, but the earliest (e.g. starts with prominent but brief automatisms and then has prolonged tonic phase – automatisms would be the descriptor used)

•   Focal to bilateral tonic-clonic

o   The term secondary generalised was avoided so ensure it was clear that the seizure has a focal onset and the bilateral spread does not have importance in aetiology

•   Awareness

o   Retained knowledge of self and environment

o   Different to responsiveness (which may also be useful to record separately)

o   It is noted that there are multiple types of altered consciousness

•   Definition

o   Originate in networks limited to one hemisphere

o   They may be discretely localised or more widely distributed

o   They may originate in subcortical structures

Generalised

•   Definition

o   Originating at some point within and rapidly engaging, bilaterally distributed networks

o   The seizure has a consistent focus of onset.

Unknown Onset

•   It is suggested that defining the onset as focal or generalised should only be done when there is a >80% chance of certainty

•   In many seizures the details surrounding the onset is unknown

•   Unknown onset should be used in these circumstances

 

•   Epilepsy syndromes will be grouped according to aetiology (see Epilepsy Syndromes)

 

New Term

Description

Old Term

Hyperkinetic

Agitated thrashing or leg pedalling movements

Hypermotor

Behaviour arrest

Arrest (pause) of activities, freezing immobilization.

 

Cognitive

Pertaining to thinking and higher cortical functions.

Specific cognitive impairments

Can be negative: E.g. aphasia, apraxia, neglect,

Can be positive: de ja vu, jamais vu, illusions, halucinations

Psychic

Epileptic spasms

A sudden flexion, extension or mixed flexion-extensionof predominantly proximal and truncal muscles that is more sustained than a myoclonic movement but less sustained than a tonic seizure.  Limited forms may occur: grimacing, head nodding or subtle eye movements.  Frequently occur in clusters.

Epileptic spasms

Emotional

E.g. Fear, Joy, laughing (gelastic), crying (dacrystic)

 

Clonic

Jerking, either symmetric or asymmetric, that is regularly repetitive and involves the same muscle groups

 

Absence

Sudden onset

Interruption of ongoing activities

Blank stare

Possible brief up-ward deviation of the eyes

Unresponsive when spoken to

A few seconds to 30sec

Very rapid recovery (with no post-ictal confusion)

Absence

Tonic

A sustained increase in muscle contraction lasting a few seconds to minutes

 

Myoclonic

Sudden, brief (<100ms) involuntary single or multiple contractions of muscles or muscle groups.

 

Absence, atypical

An absence seizure with changes in tone that are more pronounced than in typical absence OR the onset or cessation is not abrupt

Often associated with slow, irregular, generalised spike wave activity

Absence, atypical

 

 

Bold text = new ILAE terminology

Seizures

Description

EEG

Focal

Localized to discrete area’s of the cerebral cortex

 

Simple

Consciousness maintained

 

“With observable motor or autonomic symptoms”

Motor

Autonomic

 

“With subjective sensory or psychic symptoms only” = aura

Sensory

-        Usually numbness or paraesthsia, visual relatively rare, auditory and vertiginous can also occur

-        Olfactory

-        Gustatory

-        Visceral

-        Psychic

 

Complex

 

“With impairment of consciousness or awareness”

= Focal dyscognitive

Decreased awareness/ consciousness

Automatisms

Post-ictal confusion/amnesia

Psychic symptoms can occur

-        Illusions, hallucinations, dιjΰ vu, jamis vu, affective symptoms

 

Partial with secondary generalization

 

“Evolving to bilateral convulsive seizure”

Usually tonic-clonic seizure

 

Primarily generalized

Diffuse area’s of the brain simultaneously

 

Tonic-clonic

May be vague prodrome

Tonic phase 10-20sec

-        Pupils dilated and NR

Clonic phase

-        8Hz slowing to 4Hz

-        ~30s

-        Ends with deep inspiration

Gradually increasing relaxation

Usually no more than 1min

Post-ictal – unresponsive, flaccid, salivation, bowel/bladder incontinence

Tonic phase – progressive increase in generalized low-voltage fast activity followed by generalized high amplitude, polyspike discharges.

Clonic phase – spike and wave

 

Post-ictal – generalized slowing.

Absence

Brief, sudden lapses of consciousness (2-10s) without lapses of postural control

No post-ictal confusion

Subtle movements may accompany

Usually begin in childhood (4-8yrs)

15-20% of childhood seizures

60-70% resolve during adolescence

50% will also experience TC seizure

33% will have myoclonic jerks

Generalized, symmetric 3Hz spike and wave discharge that begins and ends suddenly

Hyperventilation provokes seizures and EEG changes

Typical

Atypical

With special    features

Myoclonmic absence

Eyelid myoclonia

Myoclonic

Most common with metabolic syndromes, degenerative CNS disease, anoxic brain injury

Bilateral synchronus spike and wave pattern – at time of myclonus

 

Myoclonic atonic

 

 

Myoclonic tonic

 

 

Tonic

 

 

Clonic

 

 

Atonic

Brief loss of tone 1-2 sec with loss of consciousness

No post-ictal confusion
Associated with specific syndromes

 

Unknown

 

 

Epileptic spasms

 

 

 

Clinical features (semiology)

•        Focal dyscognitive seizures

o   60% temporal vs 40% extratemporal

By Region:

Temporal lobe - Mesial (limbic)

•        FDS evolve relatively gradually (1-2min) and last longer (2-10min) than most extra-temporal seizures

Aura

•   Visceral – most common – rising epigastic sensation

•   Autonomic – pallor or flushing, BP, HR, pupil size, piloerection

•   Cephalic

•   Gustatory – taste – usually unpleasant

•   Dysmnestic – De ja vu

•   Affective - fear

Absence

•   Often a prominent feature

Automatisms

•   Often ipsilateral to side of seizure

•   Dystonic posturing usually contralateral

•   Oroalimentary – lip smaking, chewing, swallowing

•   Gestural – fumbling, fidgeting, undressing, sexually directed actions

Post-ictal

•   Dysphasia – useful lateralizing sign indicating dominant lobe focus

Temporal lobe – lateral

Aura

•   Simple auditory phenomena  - humming, buzzing, hissing, roaring – superior temporal gyrus

•   Olfactory – unpleasant and hard to define – sylvian fissure

•   Illusions of size – macropsia, micropsia

•   Illusions of weight, distance

•   Affective auras rare

Motor activity /Automatisms

•   More pronounced, less motor arrest

Frontal lobe

•   Frequent, brief attacks with tendency to cluster

•   Lack the gradual evolution of temporal lobe seizures

•   Some forms only occur from sleep

•    

•   Motor arrest rare

•   Prominent motor signs

o   Lower limbs

o   Cycling, stepping, kicking

o   Can be bizarre, highly excited. 

•   Head and eye version common

o   Head version during full consciousness is useful lateralizing sign of contralateral frontal dorsolateral anterior convexity lesion

•   2014 paper suggests 4 groups:

o   Elementary motor signs – posterior frontal lobe

o   Elementary motor signs, non-integrated gestural motor behaviour – mid frontal, opercular region

o   Integrated gestural motor behaviours, distal stereotypies – frontal pole, mesial anterior cingulate

o   Fearful behaviour – anterior mesial, cingulate

Diagram

Description automatically generated

Central (peri-rolandic)

•   Frequently simple focal seizure (without loss of awareness)

•   Contralateral clonic jerking – often with Jacksonian march)

•   Bilateral posturing

•   Fencing posture – contralateral arm abduction, elevation and flexion with head version to same side – supplementary motor area.

•   Sensory symptoms can occur – often followed by jerking movement as seizure spreads anteriorly

•   Post-ictal Todd’s paresis common

Parietal

•   Aura is common (85%)

•   Somatosensory (75%)

o   Parietal operculum

•   Often multiple aura’s in one patient

•   Illusions of body distortion

•   Illusion of body parts in space

•   Panic attacks/ictal fear

•   Ictal pain

•   Ictal vertigo

•   Mesial parietal

o   Recurrent, brief, asymmetrical tonic seizures, rapid recovery

•   Intraparietal Sulcus

o   Spinning seizures – sense of spinning, turning around while standing, rolling over in bed

•   Inferior parietal lobule

o   Often temporal like

Occipital

•   Visual symptoms

•   Elementary visual hallucinations most common – colours, shapes, flashes, patterns

•   Complex illusions can occur

•   Vision blackouts also common – but often associated with illusions.

Insula

•   Anterior

o   Abdominal pain

o   Gustatory

•   Inferior

o   Limbic symptoms

•   Posterior

o   Warmth or pain

o   Auditory

•   Ref:  Lecture at ESA 2018

Cingulate

•   Anterior

o   Anxiety, Fear

o   Hypermotor

•   Middle

o   Complex movments

•   Posterior

o   Abdominal aura

o   De ja vu

o   Hypermotor

o   Can be similar to mesial temporal semiology

•   Ref: Lecture at ESA 2018

By Symptom:

Symptom

Localisation

Lateralisation

Correlation

 

Sensory

 

 

 

 

Well-defined somatosensory symptoms

Parietal (primary sensory cortex)

Contralateral

High

 

Poorly defined somatosensory symptoms (e.g. bilateral)

Parietal (S2 or SMA)

None

Low

 

 

 

 

 

 

Gustatory Aura

Insular

 

 

 

 

 

 

 

 

Olfactory sensations

Anterior mesio- temporal lobe

None

 

?Associated with amygdala lesions

Vertigo

Insular – parietal – temporal junction

 

None

?

 

Vertigo – yaw sensation (spinning around vertical axis)

Posterior temporal

 

 

 

Vertigo – spinning around horizontal axis

Parietal opercular

 

 

 

Ascending visceral feelings

mesio – temporal, insular, supplementary motor area

None press tab moderate

 

 

Unilateral elementary visual phenomena

Occipital

Contralateral

High

Visual phenomena are often bilateral – which is non lateralising. 

Complex visual hallucinations and illusions

Parieto-temporal (association cortex)

None

?

 

Elementary auditory manifestations (if unilateral)

Primary auditory cortex

(Heschell’s gyrus)

Contralateral

Low (Lat)

It is difficult for patients to lateralise sounds. 

 

 

 

 

 

Dιjΰ vu

Mesio temporal

None

 

 

Ictal fear

Amygdala

None

 

 

Orgasmic aura

Non-dominant mesio temporal or para-sagittal parietal region

None

 

 

 

 

 

 

 

Lateralised ictal headache

Temporal or occipital

Ipsilateral

Moderate

 

Postictal headache

Non-localising

 

 

 

Pre-ictal headache

?

 

 

 

 

 

 

 

 

Motor

 

 

 

 

Forced head version (Versive seizures)

Frontal, temporal

Contralateral

High

Versive = eye, head, body movement, forced, sustained unnatural posture.  Probably due to activation of frontal eye field.  Occurs earlier in frontal lobe seizures.

Non-versive head turning

Temporal

Ipsilateral

Moderate

Often will then turn to the contralateral side as the seizure becomes bilateral TC.

Eye deviation (without head deviation)

Non-localising

 

 

 

Unilateral clonic

Frontal > temporal

Contralateral

High (~92% for Lat)

Frontal clonic – early with preserved consciousness.  Temporal clonic – may occur later, after automatisms.

Unilateral tonic

Extratemporal >>temporal

Contralateral

High (Lat)

Generated in cortical motor areas.  Only lateralising if truly unilateral. 

Unilateral dystonia

Temporal > frontal

Contralateral

High

Dystonic posturing – unnatural tonic posturing with a rotatory component.

Asymmetric termination of clonic phase

Temporal and frontal

Ipsilateral to the last cloni

High (80% for Lat)

 

Figure 4 sign

(just prior to BTCS)

SMA

Contralateral (to extended arm)

High (Lat)

Importantly its significance is limited to the situation where it occurs just prior to BTCS.

Unilateral eye blinking

Unknown

Ipsilateral (to blinking eye)

High (Lat)

Rare

Ictal Nystagmus

?Occipital

Contralateral to fast phase

?

 

Hand position

 

 

 

 

See Siegel and Tatum.  Neurology Vol 87 2016

-   Fan

Onset of GGE TCS

 

 

 

-   Fist

Tonic and clonic phase of GGE, Clonic phase of FBTCS

 

 

 

-   Index finger pointing

Onset of focal epilepsy FBTCS

 

 

 

-   Claw

Psychogenic events

 

 

 

-   Flaccid

Psychogenic events

 

 

 

Negative motor phenomena

 

 

 

 

Negative myoclonus

Central region

Contralateral

?

 

Ictal akinesia

 

Contralateral

High (Lat)

Different to dystonia which must be excluded

Negative motor area’s – anterior to face motor area in frontal lobe

 

 

 

 

 

Other

 

 

 

 

Automatisms

Temporal >frontal

Ipsilateral

High

Often associated with contralateral dystonic posturing – which has the greater lateralising significance.  Preserved responsiveness during automatisms infers right sided onset.

 

 

 

 

 

Ictal speech

Temporal

Non-dominant

High

Clearly understandable words or phrases

Autonomic

 

 

 

 

Ictal urinary urge

Temporal

Non-dominant

?

 

Ictal bradycardia

Temporal

None

 

 

Ictal tachycardia

Insula

Non-dominant

 

 

Ictal piloerection (unilateral)

Temporal

Ipsilateral

?

Rare (0.14%)

“Cold shivers”/goosebumbs

Temporal

Dominant

 

(Stefan et al 2002)

 

 

 

 

 

Ictal spitting

Temporal lobe

Non-dominant

 

Rare

Ictal vomiting

Temporal (+?insula)

Non-dominant

 

Often associated with an epigastric aura

Ictal laughing

Hypothalamic hamartoma or temporal or frontal

-

-

 

Ictal weeping (dacrystic seizures)

Mesio temporal

None

-

 

Peri-ictal water drinking

Temporal

Non-dominant

 

?Incidence up to 15%

Peri-oral myoclonia

Generalised

 

 

 

Rhythmic Ictal non-clonic Hand movements (RINCH) – simple movement, not like automatism

Temporal

Contralateral

 

 

 

 

 

 

 

Post-ictal signs

 

 

 

 

Postictal dysphasia

Dominant hemisphere

-

High

Must be distinguished from impaired consciousness

Postictal paresis (Todd’s)

Temporal or frontal

Contralateral

High (Lat)

Incidence 6-40%

Postictal nose wiping

Temporal, frontal

Ipsilateral

High (Lat 50-97%)

 

Postictal coughing

?temporal

Nil

Mod (Loc)

 

Some studies say left, others right – therefore no clear lateralising value

* From Rossetti and Kaplan (2010) Seizure semiology; European neurology.

Aetiology

Acute symptomatic seizures

 

Risk  of acute seizures

Risk of chronic seizures

Stroke

 

 

Ischaemic stroke

2.5-5.0

11

ICH

16

 

SAH

10

7

Infection

 

 

Bacterial meningitis

17-24

2.7

Encephalitis

 

>20

Cerebral abscess

17

 

Neurocysticercosis

 

 

Cerebral malaria

40

 

HIV

 

~15% pre- and 6% post HAART

Inflammatory

 

 

MS

 

~3x risk, 3.1% at 15years

ADEM

10-20

 

SLE

10-20

 

Wegener’s

<5

 

Bechcet’s

<5

 

NMDA encephalitis

75

 

Metabolic

 

 

Hyponatraemia

5-15

 

Hypernatraemia

Rare

 

Liver failure

Rare

 

Drugs

 

 

Alcohol withdrawal

33

 

Marijuana

?Nil

?Nil

Cocaine

1-8

 

Heroin use

OR 27

OR 4.7

Ketamine

?Nil

?Nil

Head injury

 

 

Closed

2-6

 

  Mild

 

Nil

  Mod

 

1-4

  Severe

 

10-15

Open

 

30-50

Neurodegenerative diseases

 

 

Alzheimer

 

6-fold risk

Huntington disease

 

5

CJD

 

10

*Acute symptomatic seizures, Practical Neurology 2012 12:154

 

Drugs

•        Alcohol

•        Acute intoxication probably does not cause seizures

•        Acute withdrawal – 6-48hours can lower seizure threshold

 

Medications

Drug

Risk

Anti-psychotics

All probably have increased risk, listed below have higher risk

 

 

Clozapine

1-4%

Chlorpromazine

1-9%

Trifluoperazine

 

Anti-depressants

Risk ranges from <1-4%

SSRI’s, MAOI’s

Lowest risk

Antibiotics

 

B-Lactams (Especially - Benzylpenicillin,cephazolin, imipenem)

 

Isoniazid

 

Quinolones (ciprofloxacin, norlfoxacin)

 

Other

 

Theophylline

High

 

 

 

Tumours

Risk of seizures:

•   DNET                              80-100%

•   Low-grade astrocytoma    75%

•   Meningioma                     30-60%

•   High-grade astrocytoma    30-50%

•   Brain metastases             20-35%

•   Primary CNS lymphoma    10%

 

Overall Causes of Seizure

Adults

•   Unknown  62%

•   Stroke 9%

•   Trauma 9%

•   Alcohol 6%

•   Neurodegenerative disease 4%

•   Encephalopathy 3.5%

•   Tumours 3%

•   Infection 2%

 

Causes of seizure (by age)

Neonates

(less than 1 month)

Hypoxia/ischaemia

ICH

Acute infection

Metabolic

Drug withdrawal

Developmental disorders

Genetic disorders

Infants and children

(1month to 12 years)

Febrile seizures

Genetic disorders

CNS infection

Developmental disorders

Trauma

Idiopathic

Adolescents

(12-18yrs)

Trauma

Genetic

Infection

Tumour

Drug use

Idiopathic

Young adults

18-35yrs

Trauma

Alcohol withdrawal

Drug use

Tumour

Idiopathic

Older adults

Over 35yrs

Cerebrovascular disease

Tumour

Alcohol withdrawal

Metabolic

Alzheimer’s/degenerative disease

Idiopathic

 

Acute symptomatic seizures

Specific Epilepsy Syndromes

 

Patient Evaluation

History

Symptoms:

Post ictal

·       Headache

Physical examination

 

Investigations

Specific Serum Markers of Seizure

•   CK

•   Prolactin

Ammonia

•   Study (2016 Epilepsia 57(8)1228) - 78 patients admitted for VEM for diagnostic purposes

o   Ammonia sample taken 15-60min post ictal

o   Baseline ammonia was slightly higher in generalised convulsive seizure group

o   Significant increase in Ammonia in generalised convulsive seizure group only (not in focal sz or PNES)

o   A cut point of >80umol/L gave Sn 53.9% and Sp 100%

EEG

Imaging

 

Differential diagnoses

 

Seizure

Syncope

Precipitating

Usu none

Stress, valsalva, cardiac event

Premonitory symptoms

None or aura

Tiredness, nausea, sweating, tunnelling of vision

Posture

Variable

Usually erect

Transition to unconciouness

Usu. Immediate

Gradual

Duration of unconsciousness

Minutes

Seconds

Duration of tonic or clonic movt.

30-60 seconds

Never more than 15sec

 

Facial appearance during event

Cyanosis, frothing at mouth

Pallor

Aching muscles after event

Often

Sometimes

Biting of tongue

Sometimes

Rarely

Incontinence

Sometimes

Sometimes

Headache

Sometimes

Rarely

 

 

 

 

Treatment:

•        Treatment of underlying condition

•        Avoidance of precipitating factors

•        Anti-epileptic drug therapy

•        Avoidance of dangerous activities

•        Driving

o   Operating machinery or at heights

o   Swimming alone

•        Treat/screen for concomitant problems

o   Depression

•        Overall effective in 60-70% of patients

 

Ketogenic Diet

•        Effective, especially in paediatric populations

•         

Surgery

•        Temporal lobe resections

o   60-70% chance of being seizure free

•        Vagal nerve stimulation

o   50% reduction in 30-40% of patients

•        Deep brain stimulation

o   Under investigation

Refer for surgery when (rule of 2’s):

·       2 years of seizures

·       >2seizures/month

·       >2monotherapies trialed

·       One trial of two drugs combined

 

Prognosis with treatment

Patterns of treatment response in newly diagnosed epilepsy,

•   Kwan Neurology 2012

•   1098 patients

•   Median F/U 7yrs

•   Seizure freedom defined as one year

 

Drug Regimens

% of total cohort Seizure free

% Seizure free on particular regimen

% polytherapy

Monotherapy

49.5

49.5

 

Second

13.3

36.7

30.8

Third

3.7

24.4

36.5

Fourth

1.0

16.2

45.5

Fifth

0.4

12.5

75

Sixth

0.2

12.5

50

Seventh

0.2

22.2

50

Eighth

0

0

 

Ninth

0

0

 

 

 

 

Monotherapy vs polytherapy

•   Only 6% of all patients achieved seizure freedom on polytherapy

•   Of the occasional successes achieved on latter drug regimens – most were on polytherapy (see table above)

 

 

Classified patients into 4 categories/patterns:

 

Pattern

A

B

C

D

Description

Becoming and remaining seizure free within 6 months of treatment

Becoming and remaining seizure free after 6 months of treatment

Fluctuating between periods of seizure freedom and relapse

Never seizure free for any complete year

%

37%

(25% immediately)

22%

16%

25%

 

Treatment withdrawal

•   Trial in late 1980’s (MRC AED Withdrawal Study Group. Lancet 1991;337:1175-80)

o   Patients seizure free for 2 years were randomised to continue treatment or wean and cease

o   At 2 years after randomisation seizure freedom was maintained in :

-   78% of patients continuing on medication

-   59% of patients who ceased

o   i.e. absolute increased risk of recurrence of 19%, NNT to result in one recurrence = 5.

•   Study from China regarding focal epilepsy (Wang et al. CNS drugs 2019, 33; 1121)

o   Patients made their own decision regarding cessation – followed for several years

o   Chance of remaining seizure free after 5 years depended on how many years the patient had been seizure free prior to medication cessation.  Ranging from 39% if seizure free for 2-3years up to 64% if seizure free 5+ years.

•   Systematic review and meta-analysis (Lamberink et al. Lancet Neurology 2017, 16:523)

o   Devised a decision tool to predict risk of seizure recurrence:

 

http://epilepsypredictiontools.info/aedwithdrawal

 

•   If a seizure is going to recur 2/3rd will happen within first year

•   If seizures occur with medication cessation 95% regained seizure control at 1 year (MRC study)

o   Other studies found figures of 76% to 85%

Changing Treatment

•   If a patient is seizure free and wishes to change treatment what is the risk of seizure?

o   12 patients changing vs matched controls (Finamore et al. Epilepsia 57(8) 1294 2016)

-   14% excess risk of seizure in next 6 months compared to controls

o   Another study suggested 18% (Wang Epilepsia 2012)

Refractory/Drug resistant Epilepsy

·       ILAE 2010

o   Epilepsy in which seizures persist and seizure freedom is very unlikely to be attained with further AED therapy

o   Failure of adequate trial of two tolerated and appropriately chosen and used AED schedules (either as monotherapy or combination) to achieve sustained seizure freedom.

Specific Anticonvulsants

Specific Issues

Driving (See Driving and Neurological Disease)

 

Epilepsy and Suicide

 

SUDEP (Sudden unexpected death in epilepsy)

Epidemiology

Chart, bar chart

Description automatically generated

 

Per 1000/year

New onset epilepsy

~ 0.35

General population of epilepsy

~ 0.9-2.3

Refractory seizures

~4.0  (1.1-5.9)

Surgery candidates/failed surgery

6.3-9.3

Associated mental retardation

~3.0

•   Incidence seems to be fairly even across age groups (children vs adults)

Pathogenesis

·       Respiratory causes probably important (apnoea seems to be important common factor)

·       ?Cerebral shutdown

·       Small proportion cardiac cause (0.1-0.4% of seizures observed to cause asystole)

 

Risk factors

·       Seizures:

o   GTCS

o   Recent or frequent seizures (>3 seizures in last year ~8x risk)

·       Medications:

o   Non-compliance

o   Recent and frequent changes in medication

o   Patients on polytherapy (polytherapy and >3seizures ~25x risk)

·       Environment

o   ?Lack of nocturnal supervision/sleeping alone

·       ?Alcohol

·       ?Depression

A screenshot of a computer

Description automatically generated with medium confidence

Table

Description automatically generated

Diagram

Description automatically generated

 

References

 

Epilepsy and Pregnancy

•   Fertility

o   Equal in young women

o   Reduced in older women with epilepsy compared to controls - ?due to decreased desire to have children or ability to have children

•   Risk of offspring developing epilepsy

o   GGE – offspring have 1/12 chance of inheriting epilepsy (~8%)

o   Focal epilepsy – offspring have 1/50 chance (2%)

o   Background rate ~1%

•   Increased maternal mortality during pregnancy

o   4-7% of all maternal deaths in UK associated with epilepsy

o   10x risk of controls

o   Largely SUDEP - ?due to coming off medication due to fear of malformations

•   Increased pregnancy complications/morbidity

o   2-4X risk of complications (Haemorrhage, transfusion, preterm delivery)

o   Caesarean section increased  – Australian pregnancy registry – 39.2% vs 29.9%

•   Seizure risk

o   Overall 15% of women with epilepsy will have GTCS during pregnancy ?unknown if this is any different from baseline

o   2/3 patients have no change in seizures during pregnancy

-   ?1/3 improve, 1/3 stay the same, 1/3 get worse

o   However clearly increased risk of seizure during delivery – 2-2.5%

o   Reasons for worse seizures during pregnancy:

-   Change in metabolism of medication

-   Vomiting

-   Sleep deprivation

-   Withdrawal of medication (due to side effect concerns)

-   ?Effect of pregnancy on seizure threshold

•   Seizure effect on foetus

o   May be a slightly higher rate of spontaneous abortions

o   One study shows association with preterm delivery and lower birth weight

o   One study demonstrated lower verbal IQ in children with 5 or more TCS during pregnancy

o   Vast majority of studies suggest increased seizures DO NOT increase rate of congenital malformation

o   Isolated focal seizures unlikely to have any significant impact

•   Discussion list:

o   Risk of medications on pregnancy

o   Risk of seizures on pregnancy

o   Folate

o   Medication adjustment during and after pregnancy

o   Morning sickness (redose if vomiting after dose – recommendations vary from 15-60min after dose)

o   Risk of seizures peri-partum

-   Avoid prolonged labour, lower threshold for pain relief

o   Sleep deprivation

o   New-born safety

-   Bathing baby

-   Red

o   Anxiety and depression

•   Effect of AEDs – See Anticonvulsants

 

Epilepsy and female hormones – menstruation and menopause

Catamenial epilepsy

3 patterns

•   C1 during menstruation

•   C2 during ovulation

•   C3 during anovulatory cycles

 

•   Majority C1

•   Trial of progesterone

o   Overall no benefit

o   Subgroup with C1 may have some benefit

 

•   Old trial (1982) suggested clobazam effective:

o   20-30mg for 10 days starting 2 days prior to usual onset of seizures.

 

Menopause

•   May get better or worse

•   More often gets worse in the perimenopause

 

Seizures from sleep

Studied in WA database (presented ESA 2015)

•   239 patients with first seizure from sleep (23% of all first seizures)

•   89 patients (40%) eventually developed an awake seizure

•   Median onset awake seizure 1.6 years (range 1-12 years)

•   13% risk of seizure in first year drops off substantially thereafter

•   After 2 consecutive sleep seizures one year risk of awake seizure is 5%

•   After 3 risk is 1.5%

References

“Evaluation of first seizure” Neurology 2007 69:pg1996-2007

“Initial Management of Epilepsy” NEJM 2008 359;2 pg166